Clinical Trials
427 trialsNeoadjuvant Immune Checkpoint Blockade in Resectable Malignant Pleural Mesothelioma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
The Lung PCA: A Multi-Dimensional Atlas of Pulmonary Premalignancy
University of Colorado, Denver
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers
University of Pittsburgh
FRONE
Institut Bergonié
A Feasibility Study to Further the Development of Lung Cancer-based Precision Medicine
University of Arkansas
LUNG-SURG-EDU
National and Kapodistrian University of Athens
A Study of Tumor-Treating Fields (TTFields) in People With Lung Adenocarcinoma
Memorial Sloan Kettering Cancer Center
A Phase 2 Study of Osimertinib in Combination With Selumetinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer
Dana-Farber Cancer Institute
High-Fermented Food Intervention Among Locally Advanced Rectal Cancer Patients (The FEED Trial)
H. Lee Moffitt Cancer Center and Research Institute
Nivolumab Plus Ramucirumab in Patients With Recurrent, Advanced, Metastatic NSCLC
Fox Chase Cancer Center
Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC
Fox Chase Cancer Center
APPROACH
Guangdong Association of Clinical Trials
SCOOT
University of Oxford
Nivolumab and Radiation Therapy With or Without Ipilimumab in Treating Patients With Brain Metastases From Non-small Cell Lung Cancer
M.D. Anderson Cancer Center
A Exploratory Study of Nivolumab Monotherapy or in Combination With Nab-paclitaxel and Carboplatin in Early Stage NSCLC in China
Guangdong Association of Clinical Trials
Aurora Kinase Inhibitor LY3295668 in Combination With Osimertinib for the Treatment of Advanced or Metastatic EGFR-Mutant Non-squamous Non-small Cell Lung Cancer
M.D. Anderson Cancer Center
Evaluation of Canakinumab in High-Risk Former-Smokers
Ohio State University Comprehensive Cancer Center
Osi+Ipi
University of Utah
STAGGER
University of Utah
Tumor-informed MRD for Non-small Cell Lung Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Pembrolizumab Every 12 Weeks Versus Every 3 Weeks in Treating Patients With Non-small Cell Lung Cancer
Roswell Park Cancer Institute
OvAR-Y
Washington University School of Medicine
Ceritinib Plus Docetaxel in ALK-Negative, EGFR WT Advanced NSCLC
H. Lee Moffitt Cancer Center and Research Institute
SURVIMON
N.N. Petrov National Medical Research Center of Oncology
Pleurectomy/Decortication (Neo) Adjuvant Chemotherapy and Intensity Modulated Radiation Therapy to the Pleura in Patients With Locally Advanced Malignant Pleural Mesothelioma
Memorial Sloan Kettering Cancer Center
ASCENT
University College, London
Self-Management Support for Lung Cancer Patients With Cachexia
Changhua Christian Hospital
HyPeR
Royal Marsden NHS Foundation Trust
DOTATOC PET/CT for Imaging NET Patients
British Columbia Cancer Agency
Emulation of the KEYNOTE-042 (NCT02220894) Trial Using Specialty Oncology Electronic Health Records Databases
Brigham and Women's Hospital
PLuS2
University of Florida
Treating Early-stage Non-Small Cell Lung Cancer With Durvalumab and Radiation Therapy
Memorial Sloan Kettering Cancer Center
Shared Decision Making on Radiation Dose for Lung Malignancies
Vejle Hospital
Safety and Tolerability of Low Dose Radiotherapy Concurrent SBRT and PD-1 Inhibitors in Advanced NSCLC.
Sichuan University
A Phase IB/II Study of Alectinib Combined With Cobimetinib in Advanced ALK-Rearranged (ALK+) NSCLC
Massachusetts General Hospital
Low-dose Radiotherapy Combined With Durvalumab, Chemotherapy(EP) in the Treatment of ES-SCLC
Sichuan University
DECANPHAR
Groupe Hospitalier de la Region de Mulhouse et Sud Alsace
ELFE
University of California, Davis
Emulation of the CheckMate 017/057 (NCT01642004 and NCT01673867) Trials Using Specialty Oncology Electronic Health Records Databases
Brigham and Women's Hospital
SARON
University College, London
Respiratory Motion-Corrected Cone-Beam CT and Intratreatment Gating Based on Electromagnetic Transponders to Reduce Target Position Uncertainty in Radiation Treatment of Lung Malignancies
Memorial Sloan Kettering Cancer Center
Safety of Lung Cryobiopsy in People With Cancer
Memorial Sloan Kettering Cancer Center
Using e-Nose Technology to Identify Early Lung Cancer
Memorial Sloan Kettering Cancer Center
Safety and Efficacy of Zimberelimab (AB122) in Combination With Domvanalimab (AB154) and Etrumadenant (AB928) in Patients With Previously Treated Non-Small Cell Lung Cancer
Washington University School of Medicine
Early Detection of Lung Cancer
Vanderbilt-Ingram Cancer Center
Microwave Ablation or Wedge Resection for the Treatment of Lung, Sarcoma and Colorectal Lesions, ALLUME Study
M.D. Anderson Cancer Center
NADIM-ADJUVANT
Fundación GECP
NIVIPI-Brain
Fundación GECP
A Pilot Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) in Central Non-Small Cell Lung Cancer
Roswell Park Cancer Institute
Benefit of Cone-beam CT and Robotic-Assisted Bronchoscopy During Bronchoscopy
University of Zurich